Ribosomal protein S20 pseudogene 32 (RPS20P32)

Ribosomal protein S20 pseudogene 32 (RPS20P32) is a processed pseudogene in the human genome, with official records such as NCBI Gene (100129306), HGNC (36444), and Ensembl (ENSG00000218198)[8][1][7]. Pseudogenes like RPS20P32 are non-functional genomic elements that resemble known protein-coding genes but do not encode active proteins. RPS20P32 is homologous to ribosomal protein S20 (RPS20), which is a structural constituent of the ribosome and relevant in protein synthesis[8][4][10]. However, unlike RPS20, RPS20P32 does not encode a functional ribosomal protein and has no established biological or disease role, known drug interactions, or therapeutic relevance[8][10]. RPS20P32 is catalogued as a pseudogene, confirmed by multiple genomic databases[8][1][7]. It does not produce a functional protein and its transcripts do not contribute to known cellular processes[8]. While some ribosomal protein pseudogenes can be transcriptionally active or involved in regulatory networks or disease processes, there is no evidence to suggest RPS20P32 has such a role[8][11]. Its parent protein, RPS20, is involved in ribosome structure and associated with several diseases (such as Diamond-Blackfan anemia)[10], but this does not extend to the pseudogene RPS20P32. In summary, RPS20P32 is not a valid therapeutic target—it is a human pseudogene without evidence of druggability, biological activity, or clinical importance, and should be carefully distinguished from the functionally important ribosomal protein S20 (RPS20)[8][1][10].

Other names

RPS20_15_1306